Ionis Pharmaceuticals, Inc. (IONS)
NASDAQ: IONS · Real-Time Price · USD
56.92
+1.50 (2.71%)
Aug 12, 2026, 12:13 PM EDT - Market open
Ionis Pharmaceuticals (IONS) Revenue by Segment
| Date | Research and Development | Commercial |
|---|---|---|
| Jun 30, 2026 | 390.30M | 483.60M |
| Mar 31, 2026 | 590.29M | 467.76M |
| Dec 31, 2025 | 507.74M | 435.92M |
| Sep 30, 2025 | 586.74M | 380.92M |
| Jun 30, 2025 | 603.82M | 340.66M |
| Mar 31, 2025 | 407.74M | 309.94M |
| Dec 31, 2024 | 412.20M | 293.36M |
| Sep 30, 2024 | 517.20M | 286.36M |
| Jun 30, 2024 | 519.24M | 294.71M |
| Mar 31, 2024 | 476.54M | 300.57M |
| Dec 31, 2023 | 479.40M | 308.75M |
| Sep 30, 2023 | 305.40M | 309.75M |
| Jun 30, 2023 | 332.63M | 298.08M |
| Mar 31, 2023 | 277.72M | 298.36M |
| Dec 31, 2022 | 284.60M | 302.88M |
| Sep 30, 2022 | 565.60M | 309.88M |
| Jun 30, 2022 | 526.51M | 322.29M |
| Mar 31, 2022 | 510.80M | 329.97M |
| Dec 31, 2021 | 468.32M | 342.13M |
| Sep 30, 2021 | 309.32M | 351.13M |